AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $172.35 million. The enterprise value is $200.21 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 30.78 million shares outstanding. The number of shares has increased by 7.64% in one year.
| Current Share Class | 30.78M |
| Shares Outstanding | 30.78M |
| Shares Change (YoY) | +7.64% |
| Shares Change (QoQ) | +7.01% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 15.78% |
| Float | 30.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.41 |
| Forward PS | 2.06 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -39.06% |
| Return on Invested Capital (ROIC) | -66.56% |
| Return on Capital Employed (ROCE) | 676.75% |
| Weighted Average Cost of Capital (WACC) | 14.56% |
| Revenue Per Employee | $316,858 |
| Profits Per Employee | -$214,987 |
| Employee Count | 226 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 1.80 |
Taxes
In the past 12 months, AVITA Medical has paid $11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.03% in the last 52 weeks. The beta is 1.89, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | -35.03% |
| 50-Day Moving Average | 4.38 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 72.73 |
| Average Volume (20 Days) | 244,967 |
Short Selling Information
The latest short interest is 3.82 million, so 12.17% of the outstanding shares have been sold short.
| Short Interest | 3.82M |
| Short Previous Month | 3.70M |
| Short % of Shares Out | 12.17% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.59 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $71.61 million and -$48.59 million in losses. Loss per share was -$1.74.
| Revenue | 71.61M |
| Gross Profit | 58.82M |
| Operating Income | -42.53M |
| Pretax Income | -48.58M |
| Net Income | -48.59M |
| EBITDA | -40.24M |
| EBIT | -42.53M |
| Loss Per Share | -$1.74 |
Full Income StatementBalance Sheet
The company has $18.19 million in cash and $46.05 million in debt, with a net cash position of -$27.86 million or -$0.91 per share.
| Cash & Cash Equivalents | 18.19M |
| Total Debt | 46.05M |
| Net Cash | -27.86M |
| Net Cash Per Share | -$0.91 |
| Equity (Book Value) | -16.65M |
| Book Value Per Share | -0.54 |
| Working Capital | -27.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.20 million and capital expenditures -$1.01 million, giving a free cash flow of -$32.20 million.
| Operating Cash Flow | -31.20M |
| Capital Expenditures | -1.01M |
| Depreciation & Amortization | 2.29M |
| Net Borrowing | n/a |
| Free Cash Flow | -32.20M |
| FCF Per Share | -$1.05 |
Full Cash Flow StatementMargins
Gross margin is 82.13%, with operating and profit margins of -59.40% and -67.85%.
| Gross Margin | 82.13% |
| Operating Margin | -59.40% |
| Pretax Margin | -67.83% |
| Profit Margin | -67.85% |
| EBITDA Margin | -56.19% |
| EBIT Margin | -59.40% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.64% |
| Shareholder Yield | -7.64% |
| Earnings Yield | -28.19% |
| FCF Yield | -18.68% |
Analyst Forecast
The average price target for AVITA Medical is $7.88, which is 40.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.88 |
| Price Target Difference | 40.71% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 36.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -10.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.49 |
| Piotroski F-Score | 2 |
